Company Overview and News

14
US judge dismisses GM ignition switch criminal case

1h channelnewsasia
A federal judge in New York on Wednesday dismissed a criminal case brought against General Motors Co in 2015 over the largest U.S. automaker's handling of an ignition-switch defect linked to 124 deaths.
GM

14
U.S. judge dismisses GM ignition switch criminal case

1h reuters
WASHINGTON (Reuters) - A federal judge in New York on Wednesday dismissed a criminal case brought against General Motors Co in 2015 over the largest U.S. automaker’s handling of an ignition-switch defect linked to 124 deaths.
GM

14
NewsWatch: 10 years after Lehman Brothers collapse, Americans reevaluated their relationship with money

1h marketwatch
Bob Lutz, a renowned “car czar” and the blunt-talking former vice chairman of General Motors, has never really been one to soft pedal his opinions, no matter how controversial or curmudgeonly they may seem. Here’s his latest on Tesla. See full story.
GM

14
Ex GM Boss: Tesla ‘Headed For The Graveyard’

3h oilprice
Tsvetana is a writer for the U.S.-based Divergente LLC consulting firm with over a decade of experience writing for news outlets such as iNVEZZ and…
GM

32
3 Companies Left Out of the Latest Trump Tariffs

5h zacks
The trade war between the U.S. and China continues to escalate, with Beijing set to impose tariffs on $60 billion in U.S. imports in response to the Trump administrations’ new set of tariffs on $200 billion in Chinese imports. Despite the mounting pressure on companies in the world’s two largest economies, some firms and their products appear to be safe.
FB FIT SPWR UNP NFLX GOOGL AAPL MSFT GM INTC

16
Bursting Another Tech Micro-Bubble

7h seekingalpha
Specifically, there are "micro-bubbles" in certain stocks, where valuations reflect expectations for future cash flows that would require unrealistically higher margins, faster growth, and larger market share.
DBX GM

14
Elon Musk doesn#39;t know how to run a car company; Tesla #39;headed for the graveyard#39;, says former GM exec

7h moneycontrol
Tesla is headed for the 'graveyard', according to former vice chairman of General Motors, Bob Lutz. Tesla CEO Elon Musk is a nice guy who doesn't know how to run a car company, Lutz's said.
GM

20
Google's New Automobile Deal to Boost Android Deployment Base

7h zacks
Alphabet’s (GOOGL - Free Report) Google has struck a major deal with the largest auto alliance comprising of Renault, Nissan and Mitsubishi. Per the recent multi-year partnership, Google will deploy its Android operating system (OS) for infotainment purpose in the cars manufactured by the auto alliance. This will enable people driving the car to access Google Maps, Google Assistant, Play Store and other important apps from the car’s dashboard.
UNP GOOGL AAPL NVDA GM

17
Summer Car Sales in Europe Soar, Jeep Sales Rise 160%

10h 247wallst
The European Automobile Manufacturers Association (ACEA) on Wednesday reported new vehicle registration totals in the European Union for the months of July and August. July sales rose by 10.5% compared with July 2017 sales, and August sales rose a blistering 31.2%. July sales totaled nearly 1.3 million new cars sold and August, typically the slowest month of the year for sales, accounted for 1.1 million sales.
F TM 7203 TYT GM FCAU TOYOF

15
Tech: Programmatic ads are changing the media

13h theedgemarkets
IF you are looking for the best-performing tech stock this year, don’t look at the usual suspects like Facebook, Amazon.com, Apple, Netflix and Google’s parent, Alphabet — the so-called FAANG names. Up over 211% this year, The Trade Desk sits at the crossroads of advertising and technology. In some ways, it is a competitor of Facebook, Google and Amazon. But more than that, this nemesis of old media — print newspapers, radio and TV — is helping transform the whole advertising landscape, including who sees ads, and where and when they see it.
BC94 SMSN NYTAB GM TTD SMSD

14
Tesla confirms criminal probe afoot following Elon Musk’s talk of going private

14h japantimes.co.jp
LOS ANGELES – Tesla confirmed Tuesday that U.S. Justice Department officials were looking into possible criminal aspects of a seemingly spontaneous, and later aborted, announcement by chief executive Elon Musk on taking the electric automaker private.
NYTAB GM

14
Tesla confirms criminal probe into Musk talk of going private

21h malaymail
SAN FRANCISCO, Sept 19 — Tesla confirmed yesterday that US Justice Department officials were looking into possible criminal aspects of a seemingly spontaneous, and later aborted, announcement by chief executive Elon Musk on taking the electric automaker private.
NYTAB GM

14
Tesla confirms criminal probe afoot into Elon Musk’s talk of going private

2018-09-18 japantimes.co.jp
LOS ANGELES – Tesla confirmed Tuesday that U.S. Justice Department officials were looking into possible criminal aspects of a seemingly spontaneous, and later aborted, announcement by chief executive Elon Musk on taking the electric automaker private.
NYTAB GM

17
Tit-For-Tat Tariffs Hurting U.S. Automakers: ETF in Focus

2018-09-18 zacks
The global auto-giants have invested more than $75 billion in the United States and their operations provide livelihood to about 130,000 Americans. But trade tensions may force these companies to reevaluate their strategies related to the United States (see:all Consumer Discretionary ETFs here). One of President Trump’s goals was to bring down the large trade deficit. The figures report otherwise as trade deficit increased to a five-month high in July, marking the worst in a month since 2015.
TM TYT TOYOF HOG CARZ 7203 GM MS

30
Zacks Investment Ideas feature highlights: Tesla, Ford and General Motors

2018-09-18 zacks - 1
Chicago, IL – September 18, 2018 – Today, Zacks Investment Ideas feature highlights Features: Tesla (TSLA - Free Report) ), Ford (F - Free Report) ) and General Motors (GM - Free Report) .
CVGI GFN GFNCP VTNR MDP CVS JOUT GFNSL GTES MDPEB HEAR GM GFDV

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: 37045V126